Innovation, Research
EG427: treating neurogenic bladder with precision gene therapy
… the Neuromuscular Disability: Physiopathology, Biotherapy and Applied Pharmacology Laboratory (END-ICAP – Université … vitro and in vivo studies, the Elpis project was awarded a development programme by SATT Paris-Saclay in 2016. This has … venture capital expert raised €12 million to launch the development of this young pharmaceutical company and recruit …Published on: